Boehringer Ingelheim Pharmaceuticals, Inc.

Form 483

Ridgefield, Connecticut, United StatesFEI 1219205Issued September 01, 2010

View FDA's Record for This Firm

Source: FDA record for this establishment. FDA publishes inspections or enforcement actions for this establishment, listed further down this page, but we have not matched this particular Form 483 to a document or an inspection date FDA has released. It stays out of the default view for that reason. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 1219205.

Observations3

Issue DateSeptember 01, 2010

StatusNo Warning Letter

Related Inspections10

Establishment Details

Firm: Boehringer Ingelheim Pharmaceuticals, Inc.
Location: Ridgefield, Connecticut, United States
FEI Number: 1219205
Product Type: Drugs
Issue Date: September 01, 2010
Country: United States

Inspection History, 2013 to 2025

NAI5

VAI5

NAI means No Action Indicated. VAI means Voluntary Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Boehringer Ingelheim Pharmaceuticals, Inc. FDA Form 483, Ridgefield, Connecticut, September 1, 2010